InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,916.00
(
-0.85%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.26
(
0.04%
)
Bitcoin
64,066.88
(
-0.33%
)
Post# of 30990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

LutherTiggs

Send PM Follow Ignore
Followers 22
Posts 1717
Boards Moderated 0
Alias Born 10/22/2013

LutherTiggs

Re: None

Monday, 09/28/2015 10:23:01 AM

Monday, September 28, 2015 10:23:01 AM

Post# of 30990
Preliminary results of Part 3?

From August 10 PR:

"The Company's previously announced "Part Three", double-blind, placebo-controlled, seven-day multiple dose study of Anatabine Citrate in healthy subjects, will likely overlap with "Part Two" and is expected to be completed with preliminary results in the third quarter 2015."

Hopefully, this means they will be announcing something publicly...although the PR does not state this explicitly.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up